glp 1 inhibitors weight loss Rx Trends: Real-World Data on GLP-1s for GLP-1 receptor agonists show anti-cancer

This phenomenon particularly impacts the midface, jawline, and temples, where fat loss leads to deepened nasolabial folds and orbital hollowing.6 GLP-1Induced Aesthetic Shifts: Redefining the Patient Archetype The widespread adoption of GLP-1 receptor agonists like semaglutide and tirzepatide for weight management and metabolic health is not only transforming patient physiology but also redefining the aesthetic consumer profile.1 These medications are associated with visible facial and body changes that are drawing new segments into the aesthetic ecosystem, many of whom are unfamiliar with traditional cosmetic interventions

Conclusion Understanding changes in clinical characteristics and treatment patterns over time among new users of SGLT2i or GLP-1 RA in the US as described in this observational study is important to inform and contextualize future studies assessing cardiorenal outcomes for these and additional treatments, including finerenone, for individuals with CKD and type 2 diabetes

[9] [10] L-carnitine has similarly been investigated in cardiovascular disease, particularly following myocardial infarction

A876104 26